Advertisement

J&J said to face demand to lift Risperdal settlement offer by $800 million

Johnson & Johnson faces a U.S. government demand to raise its offer by $800 million from an initial proposal to settle a federal civil investigation into marketing of the anti-psychotic Risperdal, according to three people familiar with the matter.

Read More
Tags:

Comments

Loading Comments Loading comments...
Advertisement